Counselors in Gilmer, TX Accepting Medicare

4 Counselors found. Showing 1 - 4

Wanda Marie Kennel, LCDC, LSBW Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 6563 Highland Rd, Gilmer, TX 75645 Phone: 903-734-5592

Barbara Lea Schovanec, L.P.C. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 703 Titus St, Gilmer, TX 75644 Phone: 903-843-5529

Leah Erickson, M.ED, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 104 N Montgomery St, Gilmer, TX 75644 Phone: 903-918-1888

Shane Michell Jackson, LPC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 115 W Tyler St, Gilmer, TX 75644 Phone: 903-746-7643    Fax: 903-843-4336

News Archive

Center for Health Studies is renamed as SEATTLE-Group Health Research Institute

SEATTLE-Group Health Research Institute is the new name of Group Health Center for Health Studies. Since 1983, it has been doing research to improve health and health care for all. The Institute is the research arm of Group Health Cooperative, and it is changing its name to reflect this relationship more clearly.

BioVex completes $70M financing to complete OncoVEX Phase III study

BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.

Alteration in tumor suppressor gene TP53 plays key role early in development of bone cancer

The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project found mutations in the tumor suppressor gene TP53 in 90 percent of osteosarcomas, suggesting the alteration plays a key role early in development of the bone cancer.

Researchers report increasing disparities between resource inputs, outcomes in biomedical research

As more money has been spent on biomedical research in the United States over the past 50 years, there has been diminished return on investment in terms of life expectancy gains and new drug approvals, two Johns Hopkins Bloomberg School of Public Health researchers say.

Read more Medical News

› Verified 6 days ago